Pius Waldmeier

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Fine Chemical Synthesis. Top assignee: Hoffmann-La Roche Inc.. Active years: 2001-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pius Waldmeier. Retrieved from https://idiyas.com/inventor/pius-waldmeier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 4)

% Patents Active = 50.0

CIPO Patents = 4

EPO Patents = 9 (Patent Applications = 7)

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

14 out of 5,027

Hoffmann-La Roche Inc.

patents

Years Active: 2001-2017

Loading Chart...

Areas of Expertise:

Propane-1-Sulfonic Acid

Isoxazolyl Compounds

Trifluoro Derivatives

Glucocorticoid Receptor

Nicotinamide Derivatives

Ethanesulfonyl-Piperidine

Pyridine Derivatives

GlyT-1 Inhibitors

Asymmetric Hydrogenation

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9556172 - Processes for the manufacture of propane-1-sulfonic acid (3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl)-amide (2017-01-31),

2. 9150594 - Processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide (2015-10-06),

3. 8779150 - Processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1 H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide (2014-07-15),

4. 8604062 - Process for the preparation of isoxazolyl-methoxy nicotinic acids (2013-12-10),

5. 8450313 - 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds (2013-05-28),

6. 8268820 - 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds (2012-09-18),

7. 8222246 - Substituted isoxazoles (2012-07-17),

8. 8138189 - Substituted benzene compounds as modulators of the glucocorticoid receptor (2012-03-20),

9. 7897621 - 2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents (2011-03-01),

10. 7812161 - Synthesis of GlyT-1 inhibitors (2010-10-12),

11. 7504544 - Asymmetric hydrogenation of 1,1,1-trifluoroacetone (2009-03-17),

12. 7160881 - [object Object] (2007-01-09),

13. 6605723 - Process for the preparation of ethanesul fonyl-piperidine derivatives (2003-08-12),

14. 6303790 - Process for the preparation of pyridine derivatives (2001-10-16),

Title: Pius Waldmeier: Innovator in Chemical Processes

Introduction

Pius Waldmeier is a notable inventor based in Wegenstetten, Switzerland. He has made significant contributions to the field of chemical processes, holding a total of 14 patents. His work focuses on innovative methods for synthesizing complex chemical compounds.

Latest Patents

Waldmeier's latest patents include novel processes for the manufacture of propane-1-sulfonic acid, specifically the compound of formula 1, which involves 3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl)-amide. These patents detail new synthesis routes for key intermediates used in these processes, showcasing his expertise in chemical manufacturing.

Career Highlights

Throughout his career, Pius Waldmeier has worked with prominent companies such as Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative approaches to chemical processes.

Collaborations

Waldmeier has collaborated with several professionals in his field, including Corey James Brumsted and Hendrik Moorlag. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Pius Waldmeier is a distinguished inventor whose work in chemical processes has led to numerous patents and advancements in the field. His innovative approaches continue to influence the industry and inspire future research.

Profile summary based on public USPTO records.